covid-19

  1. SNT Gatchaman

    Premortem skin biopsy assessing microthrombi, IFN I antiviral & regulatory proteins and complement correlates with Covid19 clinical stage, 2022

    Premortem Skin Biopsy Assessing Microthrombi, Interferon I Antiviral and Regulatory Proteins, and Complement Deposition Correlates with Coronavirus Disease 2019 Clinical Stage Jeffrey Laurence, Gerard Nuovo, Sabrina E. Racine-Brzostek, Madhav Seshadri, Sonia Elhadad, A. Neil Crowson, J. Justin...
  2. SNT Gatchaman

    Neurovascular injury with complement activation and inflammation in COVID-19, 2022, Lee ... Nath et al

    Neurovascular injury with complement activation and inflammation in COVID-19 Myoung-Hwa Lee, Daniel P. Perl, Joseph Steiner, Nicholas Pasternack, Wenxue Li, Dragan Maric, Farinaz Safavi, Iren Horkayne-Szakaly, Robert Jones, Michelle N. Stram, Joel T. Moncur, Marco Hefti, Rebecca D. Folkerth...
  3. Andy

    Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation, 2021, Fernandez, Monje, Nath et al

    Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain Preprint Abstract Survivors of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection frequently experience lingering neurological symptoms, including impairment in...
  4. SNT Gatchaman

    SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery, 2022, Frere et al

    SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery Justin J. Frere, Randal A. Serafini, Kerri D. Pryce, Marianna Zazhytska, Kohei Oishi, Ilona Golynker, Maryline Panis, Jeffrey Zimering, Shu Horiuchi, Daisy A. Hoagland, Rasmus Møller...
  5. SNT Gatchaman

    Consensus Guidance Statement on Cardiovascular Complications in PASC, 2022, AAPM&R

    Multi-Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Cardiovascular Complications in Patients with Post-Acute Sequelae of SARS-CoV- 2 Infection (PASC) American Academy of Physical Medicine & Rehabilitation PDF Jonathan Whiteson, MD, Department of...
  6. John Mac

    Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study, Huang et al, 2022

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00126-6/fulltext
  7. SNT Gatchaman

    Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes, 2021, Richardson et al

    Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes Edward Richardson, David García-Bernal, Eleonora Calabretta, Rubén Jara, Marta Palomo, Rebecca M Baron, Gregory Yanik, Jawed Fareed, Israel Vlodavsky, Massimo Iacobelli, Maribel...
  8. SNT Gatchaman

    [Preprint] SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy, Ryu et al, 2021

    SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy (Non peer-reviewed) Jae Kyu Ryu, Elif G Sozmen, Karuna Dixit, Mauricio Montano, Yusuke Matsui, Yixin Liu, Ekram Helmy, Thomas J Deerinck, Zhaoqi Yan, Renaud Schuck, Rosa Meza Acevedo, Collin M...
  9. Hutan

    Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection, 2022, Natarajan et al

    https://www.cell.com/med/fulltext/S2666-6340(22)00167-2 Highlights 1.Approximately half of COVID-19 patients shed fecal RNA in the week after infection 2. 4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis. 3. Presence of fecal SARS-CoV-2 RNA is associated with...
  10. ME/CFS Skeptic

    Long Covid epidemiology (prevalence, incidence, recovery rates)

    moved thread Ok, but most of these studies are based on confirmed PCR tests which if I understand correctly require virus particles, not necessarily antibodies. On Twitter someone pointed me to this Danish preprint which found that 16% of patients reported fatigue and 13% concentration...
  11. Mij

    CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome, 2022, Mar Guasp et al

    Patients with coronavirus disease 2019 (COVID-19) frequently develop acute encephalopathy and encephalitis, but whether these complications are the result from viral-induced cytokine storm syndrome or anti-neural autoimmunity is still unclear. In this study, we aimed to evaluate the diagnostic...
  12. Arnie Pye

    N-Acetylcysteine to Combat COVID-19: An Evidence Review, 2020, Zhongcheng Shi and Carlos Puyo

    Title : N-Acetylcysteine to Combat COVID-19: An Evidence Review Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649937/ Abstract The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant...
  13. Sly Saint

    Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates, 2022, Rutkai et al

    Abstract Neurological manifestations are a significant complication of coronavirus disease (COVID-19), but underlying mechanisms aren’t well understood. The development of animal models that recapitulate the neuropathological findings of autopsied brain tissue from patients who died from...
  14. H

    Covid-19 vaccines and vaccinations

    The Pfizer press release reports that protection is achieved 28 days after initiation of the first dose of vaccine. Whereas you can develop covid within a few days of exposure, so the virus wins that race...
  15. SNT Gatchaman

    Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers, 2022

    Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers Miguel Galan, Lorena Vigon, Daniel Fuertes, Marıa Aranzazu Murciano-Anton, Guiomar Casado-Fernandez, Susana Domınguez-Mateos, Elena Mateos, Fernando...
  16. SNT Gatchaman

    Evaluation of science advice during the COVID-19 pandemic in Sweden, Brusselaers et al, 2022

    Evaluation of science advice during the COVID-19 pandemic in Sweden Nele Brusselaers, David Steadson, Kelly Bjorklund, Sofia Breland, Jens Stilhoff Sörensen, Andrew Ewing, Sigurd Bergmann & Gunnar Steineck Abstract Sweden was well equipped to prevent the pandemic of COVID-19 from becoming...
  17. Andy

    Erythrocytes Induce Vascular Dysfunction in COVID-19, 2022, Mahdi et al

    Highlights • Patients hospitalized for COVID-19 display marked impairment in endothelial function, which is persistent following recovery from the acute infection. • Red blood cells (RBCs) from patients with COVID-19 impair vascular function through mechanisms involving increased arginase 1...
  18. SNT Gatchaman

    SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism, Kronstein‐Wiedemann et al, 2022

    SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism Romy Kronstein‐Wiedemann, Marlena Stadtmüller, Sofia Traikov, Mandy Georgi, Madeleine Teichert, Hesham Yosef, Jan Wallenborn, Andreas Karl, Karin Schütze, Michael Wagner, Ali El‐Armouche, Torsten Tonn...
  19. SNT Gatchaman

    Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning, Mueller, 2022

    Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning Yvonne M. Mueller, Thijs J. Schrama, Rik Ruijten, Marco W. J. Schreurs, Dwin G. B. Grashof, Harmen J. G. van de Werken, Giovanna Jona Lasinio, Daniel...
  20. mango

    The Atlantic: The Millions of People Stuck in Pandemic Limbo, 2021, Ed Yong

    The Millions of People Stuck in Pandemic Limbo https://www.theatlantic.com/health/archive/2022/02/covid-pandemic-immunocompromised-risk-vaccines/622094/ In his newsletter Ed Yong writes: "I wrote a long feature about immunocompromised people—what they’ve been through, their frustrations, and...
Back
Top Bottom